The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
N | Nervous system | |
2
|
N03 | Antiepileptics | |
3
|
N03A | Antiepileptics | |
4
|
N03AX | Other antiepileptics | |
5
|
N03AX25 |
| Active Ingredient |
|---|
|
Cenobamate is a small molecule with a dual mechanism of action. It is a positive allosteric modulator of subtypes of the γ-aminobutyric acid (GABAA) ion channel, that does not bind to the benzodiazepine binding site. Cenobamate has also been shown to reduce repetitive neuronal firing by enhancing the inactivation of sodium channels and by inhibiting the persistent component of the sodium current. |
| Document | Type | Information Source | |
|---|---|---|---|
| ONTOZRY Tablet / Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XCOPRI Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.